Aenova Holding GmbH

The Aenova Group is a leading global contract manufacturer and development services provider for the pharmaceutical and healthcare industry. They provide services covering the entire value chain from development to commercialization for all common product groups and dosage forms (solid, semisolid, sterile, and nonsterile liquid). Aenova supplies drugs up to OEB 5 and food supplements for human and veterinary use. They are also able to handle differentiated technologies such as HPAPI containment, low-dose, modified release formulations, organic granulation, particulate systems, lipid-based formulas, HME or spray drying for poorly soluble compounds. Aenova offers customers a wide-ranging service portfolio and challenges itself to expedite time to market and facilitate the drug development journey. The one-stop-shop experience stretches from early phase formulation and product development to the purchase of raw materials, analytics, regulatory support, small and full-scale production, market release through to packaging and logistics. Aenova develops, produces and packages across a network of 14 sites with a highly motivated team of nearly 4,000 employees in Europe and the USA.